KR850000073B1 - 5-(2-포르밀-3-히드록시페녹시)펜타노익 산류의 제조방법 - Google Patents

5-(2-포르밀-3-히드록시페녹시)펜타노익 산류의 제조방법 Download PDF

Info

Publication number
KR850000073B1
KR850000073B1 KR1019800002541A KR800002541A KR850000073B1 KR 850000073 B1 KR850000073 B1 KR 850000073B1 KR 1019800002541 A KR1019800002541 A KR 1019800002541A KR 800002541 A KR800002541 A KR 800002541A KR 850000073 B1 KR850000073 B1 KR 850000073B1
Authority
KR
South Korea
Prior art keywords
formyl
formula
hydroxyphenoxy
acid
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019800002541A
Other languages
English (en)
Korean (ko)
Other versions
KR830002693A (ko
Inventor
죠프리닌
Original Assignee
더 웰컴 파운데이숀 리미티드
미첼 피터 잭슨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더 웰컴 파운데이숀 리미티드, 미첼 피터 잭슨 filed Critical 더 웰컴 파운데이숀 리미티드
Publication of KR830002693A publication Critical patent/KR830002693A/ko
Priority to KR1019840001263A priority Critical patent/KR850000072B1/ko
Application granted granted Critical
Publication of KR850000073B1 publication Critical patent/KR850000073B1/ko
Expired legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/125—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/30—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing —CHO groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/74—Unsaturated compounds containing —CHO groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1019800002541A 1979-06-29 1980-06-27 5-(2-포르밀-3-히드록시페녹시)펜타노익 산류의 제조방법 Expired KR850000073B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019840001263A KR850000072B1 (ko) 1979-06-29 1984-03-13 5-(2-포르밀-3-히드록시페녹시)펜타노익산류

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7922781 1979-06-29
GB7922781 1979-06-29

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1019840001263A Division KR850000072B1 (ko) 1979-06-29 1984-03-13 5-(2-포르밀-3-히드록시페녹시)펜타노익산류

Publications (2)

Publication Number Publication Date
KR830002693A KR830002693A (ko) 1983-05-30
KR850000073B1 true KR850000073B1 (ko) 1985-02-18

Family

ID=10506199

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1019800002541A Expired KR850000073B1 (ko) 1979-06-29 1980-06-27 5-(2-포르밀-3-히드록시페녹시)펜타노익 산류의 제조방법
KR1019840001263A Expired KR850000072B1 (ko) 1979-06-29 1984-03-13 5-(2-포르밀-3-히드록시페녹시)펜타노익산류

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1019840001263A Expired KR850000072B1 (ko) 1979-06-29 1984-03-13 5-(2-포르밀-3-히드록시페녹시)펜타노익산류

Country Status (18)

Country Link
US (1) US4410537A (enExample)
EP (1) EP0022229B1 (enExample)
JP (1) JPS5649335A (enExample)
KR (2) KR850000073B1 (enExample)
AU (1) AU545274B2 (enExample)
DE (1) DE3061269D1 (enExample)
DK (1) DK159770C (enExample)
FI (1) FI71929C (enExample)
GB (1) GB2053218B (enExample)
GR (1) GR68748B (enExample)
HU (1) HU190774B (enExample)
IL (1) IL60422A (enExample)
IT (1) IT1133025B (enExample)
MW (1) MW2380A1 (enExample)
OA (1) OA06699A (enExample)
ZA (1) ZA803880B (enExample)
ZM (1) ZM5780A1 (enExample)
ZW (1) ZW14480A1 (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2090830B (en) * 1980-12-18 1984-09-26 Wellcome Found Formyl ether derivatives
GB8606913D0 (en) * 1986-03-20 1986-04-23 Hider R C Treatment of sickle cell disease
US6083522A (en) 1997-01-09 2000-07-04 Neucoll, Inc. Devices for tissue repair and methods for preparation and use thereof
RU2300516C2 (ru) * 1999-11-05 2007-06-10 Эмисфере Текнолоджиз, Инк. Соединения феноксикарбоновой кислоты и композиции для доставки активных веществ
US7279597B1 (en) 1999-11-05 2007-10-09 Emisphere Technologies, Inc. Phenyl amine carboxylic acid compounds and compositions for delivering active agents
US7129274B1 (en) 1999-11-05 2006-10-31 Emisphere Technologies Inc. Phenoxy carboxylic acid compounds and compositions for delivering active agents
AU2622301A (en) * 1999-11-05 2001-05-14 Emisphere Technologies, Inc. Phenyl amine carboxylic acid compounds and compositions for delivering active agents
WO2001070663A2 (en) * 2000-03-17 2001-09-27 Corixa Corporation Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors
US8246969B2 (en) 2001-11-16 2012-08-21 Skinmedica, Inc. Compositions containing aromatic aldehydes and their use in treatments
CN103442702B (zh) 2011-01-07 2016-02-10 阿勒根公司 黑色素改良组合物及其使用方法
CA3142817A1 (en) 2011-12-28 2013-07-04 Global Blood Therapeutics, Inc. Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation
ES2790358T3 (es) * 2011-12-28 2020-10-27 Global Blood Therapeutics Inc Compuestos de heteroaril aldehído sustituido y métodos para su uso en el aumento de la oxigenación tisular
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9604999B2 (en) 2013-03-15 2017-03-28 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10100043B2 (en) 2013-03-15 2018-10-16 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
EP3919056B1 (en) 2013-03-15 2024-08-28 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
EP2968299B1 (en) 2013-03-15 2021-01-20 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
CN112500338A (zh) 2013-03-15 2021-03-16 全球血液疗法股份有限公司 化合物及其用于调节血红蛋白的用途
EP3036222A2 (en) * 2013-08-23 2016-06-29 Virginia Commonwealth University Ester nitrates derivatives of aromatic aldehydes with multiple pharmalogic properties to treat sickle cell disease
EA202092627A1 (ru) 2013-11-18 2021-09-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
SG10201911662YA (en) 2014-02-07 2020-02-27 Global Blood Therapeutics Inc Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
HK1249052A1 (zh) 2015-03-06 2018-10-26 BeyondSpring Pharmaceuticals Inc. 治疗与ras突变相关的癌症的方法
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
HUE072191T2 (hu) 2015-12-04 2025-10-28 Global Blood Therapeutics Inc A 2-hidoxi-6-((2-(1-izopropil-1H-pirazol-5-il)piridin-3-il)metoxi)benzaldehid adagolási rendje
SG11201806583XA (en) * 2016-02-08 2018-09-27 Beyondspring Pharmaceuticals Inc Compositions containing tucaresol or its analogs
TWI825524B (zh) 2016-05-12 2023-12-11 美商全球血液治療公司 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法
BR112018074990A2 (pt) 2016-06-06 2019-03-12 Beyondspring Pharmaceuticals, Inc. composição, usos e método para reduzir neutropenia
TWI778983B (zh) 2016-10-12 2022-10-01 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
US11633393B2 (en) 2017-01-06 2023-04-25 Beyondspring Pharmaceuticals, Inc. Tubulin binding compounds and therapeutic use thereof
EP3576733A4 (en) 2017-02-01 2020-11-25 Beyondspring Pharmaceuticals, Inc. NEUTROPENIA REDUCTION METHOD
WO2019182938A1 (en) * 2018-03-22 2019-09-26 Virginia Commonwealth University Aromatic aldehydes with sustained and enhanced in vitro and in vivo pharmacologic activity to treat sickle cell disease
US11014884B2 (en) 2018-10-01 2021-05-25 Global Blood Therapeutics, Inc. Modulators of hemoglobin
CR20210335A (es) 2018-11-19 2021-09-14 Global Blood Therapeutics Inc Compuestos de 2-formil-3-hidroxifeniloximetilo capaces de modular la hemoglobina
US12479816B2 (en) 2019-02-08 2025-11-25 University of Pittsburgh—of the Commonwealth System of Higher Education 20-HETE formation inhibitors
EP4319751A4 (en) 2021-04-09 2025-02-26 Beyondspring Pharmaceuticals, Inc. THERAPEUTIC COMPOSITIONS AND METHODS FOR THE TREATING OF TUMORS
AU2023376662B2 (en) * 2022-11-07 2025-06-05 Children's Hospital Of Philadelphia (Chop) Benzaldehyde compounds with direct polymer destabilizing effects to treat sickle cell disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL105100C (enExample) * 1958-04-30
CH543472A (fr) * 1969-01-31 1973-10-31 Orchimed Sa Procédé pour la préparation d'acides phénoxyalcoyl-carboxyliques
DE2209128C3 (de) 1971-03-05 1981-10-22 CIBA-GEIGY AG, 4002 Basel Bis-Stilbenverbindungen, Verfahren zu deren Herstellung und deren Verwendung als optische Aufheller
CH550776A (de) 1971-03-05 1974-06-28 Ciba Geigy Ag Herstellung neuer bis-stilbenverbindungen.
GB1511645A (en) 1974-05-31 1978-05-24 Univ Ife Sickle cell anaemia treatment
US4137309A (en) * 1976-10-14 1979-01-30 The Procter & Gamble Company Therapeutic treatment

Also Published As

Publication number Publication date
IL60422A (en) 1984-06-29
US4410537A (en) 1983-10-18
EP0022229B1 (en) 1982-12-08
EP0022229A1 (en) 1981-01-14
GR68748B (enExample) 1982-02-16
AU545274B2 (en) 1985-07-11
DE3061269D1 (en) 1983-01-13
FI71929B (fi) 1986-11-28
IT1133025B (it) 1986-07-09
GB2053218A (en) 1981-02-04
KR850000072B1 (ko) 1985-02-18
DK159770B (da) 1990-12-03
AU5969780A (en) 1981-01-08
ZA803880B (en) 1982-02-24
GB2053218B (en) 1984-01-25
IL60422A0 (en) 1980-09-16
JPH0154339B2 (enExample) 1989-11-17
KR840004668A (ko) 1984-10-22
KR830002693A (ko) 1983-05-30
ZM5780A1 (en) 1983-11-21
IT8049108A0 (it) 1980-06-27
JPS5649335A (en) 1981-05-02
MW2380A1 (en) 1982-03-10
OA06699A (fr) 1982-05-31
DK279780A (da) 1980-12-30
FI71929C (fi) 1987-03-09
FI802052A7 (fi) 1980-12-30
ZW14480A1 (en) 1982-03-17
DK159770C (da) 1991-04-22
HU190774B (en) 1986-11-28

Similar Documents

Publication Publication Date Title
KR850000073B1 (ko) 5-(2-포르밀-3-히드록시페녹시)펜타노익 산류의 제조방법
US4530800A (en) Perylene derivatives
US3261859A (en) Basically substituted phenyl acetonitrile compounds
US4511582A (en) Phenanthrene derivatives
US4551282A (en) Triphenylene derivatives
JPS6089474A (ja) モルフイナン誘導体，その製造方法，及び該化合物を含有する抗腫瘍剤
PL154186B1 (en) Method for manufacturing arylic derivatives of the hydroxamic acid
US4656192A (en) Tropolone derivatives, processes for the preparation thereof and the use thereof as anti-tumor agents
FR2567510A1 (fr) Composes d'aminophenol et compositions pharmaceutiques les contenant
US4334089A (en) Substituted oxocarboxylic acids, processes for their preparation, their use and medicaments containing them
US4039589A (en) α-Substituted benzhydrol derivatives and a process for the preparation thereof
AU713777B2 (en) Chroman derivatives
WO1992004020A1 (en) Method of inhibiting superoxide generation
GB1559977A (en) Amines
US4946963A (en) Compounds for the control of hyperlipidemia using N-substituted isoxazolidine-3,5-diones
US3856951A (en) Substituted benzoic acid hypoliphemic agents
EP0103265B1 (en) Biphenylylpropionic acid derivative, process for preparing the same and pharmaceutical composition containing the same
JP2000511916A (ja) ポリオールスクシネートおよびその医薬製剤
JPH0789920A (ja) 新規な化合物
PL178458B1 (pl) Kompozycja farmaceutyczna do leczenia nowotworów lub chorób powstających w skutek nieprawidłowej i nadmiernej proliferacji komórek
US4717729A (en) Triphenylene derivatives
ES2221237T3 (es) Compuestos sustituidos de difenil-indanona, indano e indol y sus analogos, utiles en el tratamiento o prevencion de enfermedades caracterizadas por proliferacion celular anormal.
US4065571A (en) Antiviral 5-(substituted benzal) hydantoins
JPS6322069A (ja) 複素多環式芳香族化合物
KR880001754B1 (ko) 에테르류 화합물의 제조방법

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19800627

PG1501 Laying open of application
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19830809

Patent event code: PE09021S01D

PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19840613

Patent event code: PE09021S01D

PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

Patent event date: 19841231

PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19850425

PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19850502

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19850502

End annual number: 3

Start annual number: 1

PR1001 Payment of annual fee

Payment date: 19871228

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 19881228

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 19900104

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 19901226

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 19911226

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 19930212

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 19940204

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 19950216

Start annual number: 11

End annual number: 11

PC1801 Expiration of term